Charles River Laboratories Announces Second-Quarter 2018 Results from Continuing Operations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Charles River Laboratories (CRL) Tops Q2 EPS by 16c; Raises Outlook
August 8, 2018 7:03 AM EDTCharles River Laboratories (NYSE: CRL) reported Q2 EPS of $1.62, $0.16 better than the analyst estimate of $1.46. Revenue for the quarter came in at $585.3 million versus the consensus estimate of $571.33 million.
GUIDANCE:
Charles River Laboratories sees FY2018 EPS of $5.85-$6.00, versus... More
